GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » New Horizon Health Ltd (HKSE:06606) » Definitions » Net Cash per Share

New Horizon Health (HKSE:06606) Net Cash per Share : HK$2.36 (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is New Horizon Health Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). New Horizon Health's Net Cash per Share for the quarter that ended in Jun. 2023 was HK$2.36.

The historical rank and industry rank for New Horizon Health's Net Cash per Share or its related term are showing as below:

HKSE:06606' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 5.12   Med: 7.65   Max: 14.51
Current: 5.99

During the past 5 years, the highest Price-to-Net-Cash Ratio of New Horizon Health was 14.51. The lowest was 5.12. And the median was 7.65.

HKSE:06606's Price-to-Net-Cash is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 7.055 vs HKSE:06606: 5.99

New Horizon Health Net Cash per Share Historical Data

The historical data trend for New Horizon Health's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Horizon Health Net Cash per Share Chart

New Horizon Health Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Net Cash per Share
-1.35 -1.50 -3.76 4.32 2.30

New Horizon Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only 5.46 4.32 3.37 2.30 2.36

Competitive Comparison of New Horizon Health's Net Cash per Share

For the Medical Devices subindustry, New Horizon Health's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


New Horizon Health's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, New Horizon Health's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where New Horizon Health's Price-to-Net-Cash falls into.



New Horizon Health Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

New Horizon Health's Net Cash per Share for the fiscal year that ended in Dec. 2022 is calculated as

Net Cash per Share (A: Dec. 2022 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(1496.745-506.068-0)/430.002
=2.30

New Horizon Health's Net Cash per Share for the quarter that ended in Jun. 2023 is calculated as

Net Cash per Share (Q: Jun. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(1833.048-754.296-0)/457.601
=2.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


New Horizon Health  (HKSE:06606) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


New Horizon Health Net Cash per Share Related Terms

Thank you for viewing the detailed overview of New Horizon Health's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


New Horizon Health (HKSE:06606) Business Description

Traded in Other Exchanges
Address
400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
Executives
Invesco Advisers, Inc. 2102 Investment manager
Chen Yiyou 2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited 2301 Trustee
Bancasa Holding Limited 2201 Interest of corporation controlled by you
Mst Development Limited 2101 Beneficial owner
Yao Naxin 2305 Beneficiary of a trust
Janus Henderson Group Plc 2102 Investment manager
Jpmorgan Chase & Co. 2106 Person having a security interest in shares
Invesco Developing Markets Fund 2106 Person having a security interest in shares
Zhu Yeqing 2101 Beneficial owner
Qiming Venture Partners V, L.p.
Qiming Gp V, L.p.
Qiming Corporate Gp V, Ltd.
Bei Jing Jun Qi Jia Rui Qi Ye Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you

New Horizon Health (HKSE:06606) Headlines

No Headlines